全文获取类型
收费全文 | 17270篇 |
免费 | 1472篇 |
国内免费 | 375篇 |
专业分类
耳鼻咽喉 | 63篇 |
儿科学 | 385篇 |
妇产科学 | 183篇 |
基础医学 | 1260篇 |
口腔科学 | 164篇 |
临床医学 | 2972篇 |
内科学 | 3944篇 |
皮肤病学 | 84篇 |
神经病学 | 737篇 |
特种医学 | 1469篇 |
外国民族医学 | 3篇 |
外科学 | 2024篇 |
综合类 | 2269篇 |
预防医学 | 909篇 |
眼科学 | 169篇 |
药学 | 1525篇 |
24篇 | |
中国医学 | 293篇 |
肿瘤学 | 640篇 |
出版年
2024年 | 37篇 |
2023年 | 276篇 |
2022年 | 522篇 |
2021年 | 718篇 |
2020年 | 760篇 |
2019年 | 693篇 |
2018年 | 677篇 |
2017年 | 690篇 |
2016年 | 661篇 |
2015年 | 659篇 |
2014年 | 1175篇 |
2013年 | 1410篇 |
2012年 | 977篇 |
2011年 | 1028篇 |
2010年 | 789篇 |
2009年 | 880篇 |
2008年 | 793篇 |
2007年 | 809篇 |
2006年 | 678篇 |
2005年 | 572篇 |
2004年 | 449篇 |
2003年 | 405篇 |
2002年 | 361篇 |
2001年 | 330篇 |
2000年 | 276篇 |
1999年 | 232篇 |
1998年 | 199篇 |
1997年 | 196篇 |
1996年 | 190篇 |
1995年 | 179篇 |
1994年 | 200篇 |
1993年 | 151篇 |
1992年 | 135篇 |
1991年 | 115篇 |
1990年 | 91篇 |
1989年 | 86篇 |
1988年 | 88篇 |
1987年 | 76篇 |
1986年 | 76篇 |
1985年 | 95篇 |
1984年 | 74篇 |
1983年 | 28篇 |
1982年 | 58篇 |
1981年 | 49篇 |
1980年 | 48篇 |
1979年 | 32篇 |
1978年 | 24篇 |
1977年 | 21篇 |
1976年 | 15篇 |
1974年 | 9篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
5.
目的研究糖尿病并发抑郁症患者运动依从性的影响因素,探讨有效的干预措施。方法选择2018年11月-2019年8月天津市公安医院收治的糖尿病患者158例为研究对象,根据抑郁自评量表(CES-D)调查情况分为糖尿病抑郁(DDM)组和糖尿病非抑郁(NDDM)组各79例,采用问卷的形式分析个体化健康教育指导前后患者运动依从性影响因素。结果 NDDM组患者运动依从性量表评分为(78.4±3.3)分,高于DDM组的(52.7±4.1)分;重度抑郁患者较轻度抑郁患者运动治疗依从性明显降低;两组患者个体化健康教育后运动依从性量表评分较教育前均提高,差异均有统计学意义(P<0.01)。不同运动依从性的糖尿病患者性别、婚姻状况、文化程度、家庭支持、医患关系、并发症数量、住院次数、BMI、HbA1c比较差异有统计学意义(P<0.05)。结论抑郁症对糖尿病患者的运动依从性有明显影响,且抑郁程度越重运动依从性越差。个体化健康教育能有效改善糖尿病并发抑郁症患者的运动依从性,值得临床进一步研究。 相似文献
6.
7.
8.
《Journal of vascular and interventional radiology : JVIR》2020,31(7):1103-1109
PurposeTo explore the safety and effectiveness of bronchial artery (BA) embolization (BAE) in children with pulmonary hemorrhage.Materials and MethodsBetween February 2016 and February 2019, 41 patients (median age, 4 y; interquartile range, 2.3-8 y; median weight, 17.6 kg; interquartile range, 12.3–23.6 kg) underwent BAE. The indication of BAE included massive hemoptysis in 10 patients (24.4%), recurrent hemoptysis in 18 patients (43.9%), and refractory anemia in 13 patients (31.7%). The main etiology of pulmonary hemorrhage included pulmonary hemosiderosis (58.5%), congenital heart disease (17.1%), and infection (14.6%). A retrospective review was conducted of clinical outcomes of BAE.ResultsThere were 44 embolization sessions, with a total of 137 embolized vessels. Pulmonary hemorrhage was caused by BAs in 30 cases, nonbronchial systemic arteries plus BAs in 10, and nonbronchial systemic arteries in 1. Embolic particles were used in 30 cases (24 polyvinyl alcohol [PVA] and 6 microsphere), coils in 9 cases, and particles plus coils in 5 cases (4 PVA and 1 microsphere). Technical success (ability to embolize abnormal vessel) was achieved in 97.6% of patients (40 of 41), and clinical success (complete or partial resolution of hemoptysis within 30 days of embolization) was achieved in 90.2% (37 of 41). There was 1 procedure-related complication (2.4%) of cerebral infarction and 1 death from multiple-organ dysfunction (2.4%). Bleeding-free survival rates at 6, 12, 24, and 36 months were 92.5%, 83.9%, 83.9%, and 70.8%, respectively.ConclusionsBAE is a safe and effective procedure in children with pulmonary hemorrhage. 相似文献
9.
10.
Aditya Kelkar Caroll Webers Rohit Shetty Jai Kelkar Nikhil Labhsetwar Abhishek Pandit Madhulika Malode Sayali Tidke 《Indian journal of ophthalmology》2020,68(10):2143
Purpose:To evaluate the rate of compliance and the reasons for loss to follow-up in Indian patients with diabetic macular edema (DME), age-related macular degeneration (AMD), and retinal vein occlusion (RVO) being treated with anti-vascular endothelial growth factor (VEGF) therapy.Methods:This was a retrospective single-center study. Patients with DME, AMD, or RVO were eligible if they initiated anti-VEGF therapy between January 2013 and December 2017. Patients'' data were obtained from hospital electronic records, including the number of injections received, visits, details of follow-up, missed appointments, and reasons for loss to follow-up (>365 days).Results:A total of 648 patients were eligible for the study, of which 334 (51.54%) patients were lost to follow-up. Overall, 343 (64.96%) were males and the overall mean (SD) age was 66.40 (7.44) years. A total of 376 (58.0%) patients had a history of diabetes and 364 (56.2%) patients had a history of hypertension. Further, 127 (38.0), 112 (33.5), and 95 (28.4) had DME, AMD, and RVO, respectively and were lost to follow-up. The most commonly reported reason for loss to follow-up was “non-affordability” (n = 120; 41.1%) followed by “no improvement in vision” (n = 83; 28.4%). “No improvement in vision” (42.2%) and “non-affordability” (37.5%) were higher among patients with DME. No association was found in gender- and treatment-wise distribution of reasons for loss to follow-up.Conclusion:The results showed that around half of the patients with DME, AMD, and RVO were lost to follow-up to intravitreal anti-VEGF therapy, and the most common factors were “non-affordability” and “no improvement in vision.” 相似文献